The healthcare and technology synergy (HATS) framework for comparative effectiveness research as part of evidence-based practice in vascular access

JAVA - Journal of the Association for Vascular Access

Volumn 18, Issue 3, 2013, Pages 169-174

  Chernecky, Cynthia ^a   Zadinsky, Julie ^a   Macklin, Denise ^b   Maeve, M Katherine ^a,c  

^a AUGUSTA UNIVERSITY   (United States)

^b Charlie Norwood VAMC ^*

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Catheter related bloodstream infections; Comparative effectiveness research; Evidence based practice; Health care and technology synergy; Health care associated infections; Vascular access

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; SILVER; ZINC;

ARTICLE; BACTERIAL GROWTH; BLOOD PRESSURE CUFF; BURN DRESSING; CATHETER INFECTION; COMPARATIVE EFFECTIVENESS; CONCEPTUAL FRAMEWORK; EVIDENCE BASED PRACTICE; GAUZE DRESSING; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HOSPITAL INFECTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTRAVENOUS CATHETER; NURSING CARE; NURSING EDUCATION; NURSING PRACTICE; NURSING RESEARCH; OCCLUSIVE DRESSING; PATIENT SATISFACTION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; QUALITY OF LIFE; VASCULAR ACCESS;

EID: 84893135280     PISSN: 15528855     EISSN: 15571289     Source Type: Journal    
DOI: 10.1016/j.java.2013.05.001     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. Healthcareassociated infections (HAIs). http://www.cdc.gov/HAI/ infectionTypes.html. Accessed May 21, 2013.
2. Congressional Budget Office. Research on the comparative effectiveness of medical treatments: issues and options for an expanded federal role. 2007. http://www.cbo.gov/ publication/41655. Accessed May 21, 2013.
3. Mushlin AI, Hall WJ, Zwanziger J, et al. The costeffectiveness of automatic implantable cardiac defibrillators: results from MADIT. Circulation. 1998;97(21): 2129-2135.
4. Pollack A. The evidence gap: the minimal impact of a big hypertension study. New York Times. November 28, 2008: B1.
5. Lauer MS. Comparative effectiveness research: the view from the NHLBI. J Am Coll Cardiol. 2009;53(12): 1084-1086.
6. Kostensalo I, Seppanen M, Makela K, et al. Early results of large head metal-on-metal hip arthroplasties. Scand J Surg. 2012;101(1):62-65.
7. Macklin D. Catheter management. Semin Oncol Nurs. 2010;26(2):113-120.
8. O'Grady NP, Alexander M, Burns LA, et al. and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections 2011. http://www. cdc.gov/hicpac/pdf/ guidelines/bsi-guidelines-2011.pdf. Accessed May 21, 2013.
9. Emerson CB, Eyzaguirre LM, Albrecht JS, et al. Healthcare-associated infection and hospital readmission. Infect Control Hosp Epidemiol. 2012;33(6):539-544.
10. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132(5):391-402.
11. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159-1171.
12. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
13. Klevens RM, Edwards JR, Richards Jr CL, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122(2): 160-166.
14. Pronovost PJ, Marsteller JA, Goeschel CA. Preventing bloodstream infections: a measurable national success story in quality improvement. Health Aff. 2011;30(4):628-634.
15. National Comprehensive Unit-Based Safety Program. National implementation of the comprehensive unitbased safety program to eliminate health care-associated infections web site. http://www.onthecuspstophai.org. Accessed May 21, 2013.
16. Kusek L. Preventing central line-associated bloodstream infections. J Nurs Care Qual. 2012;27(4):283-287.
17. Bernard G, Seguy D, Alfandari S, et al. Factors associated with recurrence of catheter-related bloodstream infections in home parenteral nutrition patients. Eur J Clin Mibrobiol Infect Dis. 2012;31(11):2929-2933.
18. Cecinat V, Brescia L, Tagliaferri L, Giordano P, Esposito S. Catheter-related infections in pediatric patients with cancer. Eur J Clin Mibrobiol Infect Dis. 2012;31(11): 2869-2877.
19. Dal Molin A, DiMassimo DS, Braggion C, et al. Totally implantable central venous access ports in patient with cystic fibrosis: a multicenter prospective cohort study. J Vasc Access. 2012;13(3):290-295.
20. Lissauer ME, Leekha S, Preas MA, Thom KA, Johnson SB. Risk factors for central-line associated bloodstream infections in the era of best practice. J Trauma Acute Care Surg. 2012;72(5):1174-1180.
21. Wu PP, Liu CE, Chang CY, et al. Decreasing catheterrelated bloodstream infections in the intensive care unit: interventions in a medical central in central Taiwan. J Micro Immunol Infect. 2012;45(5):370-376.
22. Karki S, Cheng AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections ad colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012;82(2):71-84.
23. Fontana C, Favaro M, Bossa MC, et al. Improved diagnosis of central venous catheter-related bloodstream infections using the HB&L UROQUATTROTM system. Eur J Clin Mibrobiol Infect Dis. 2012;31(11):3139-3144.
24. The Joint Commission. Preventing central line-associated bloodstream infections: a global challenge, a global perspective. 2012. http://www. jointcommission.org/assets/1/18/CLABSI-Monograph.pdf. Accessed May 21, 2013.
25. Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Resp Crit Care Med. 2012;186(12):1272-1278.
26. McMullan C, Propper G, Schuhmacher C, et al. A multidisciplinary approach to reduce central lineassociated bloodstream infections. Jt Comm J Qual Patient Saf. 2012;39(2):61-69.
27. Jarvis WR. Choosing the best design for IV needleless connectors to prevent HAIeBSI. Infect Control Today. 2010;14:30-31.
28. Harnage S. Seven years of zero central-line-associated bloodstream infections. Br J Nurs. 2012;21(21). S6, S8, S10eS12.
29. Food and Drug Administration Letter to infection control practitioners regarding positive displacement needleless connectors. 2010. http://www.fda.gov/MedicalDevices/ Safety/AlertsandNotices/ucm220459.htm. Accessed May 21, 2013.
30. Chernecky C, Waller J. Comparison of bacterial CFUs in five intravenous connectors. Clin Nurs Res. 2010;19(4): 416-428.
31. Macklin D, Chernecky C, Jarvis WR, Waller J. Clinical comparisons of split septum, positive and negative mechanical valve intravenous connectors to an intraluminal protection device on infection rates. Poster presented at the Association for Professionals in Infection Control and Epidemiology 2011 Annual Conference, Baltimore, MD, June 28, 2011.
32. Glance LG, Stone PW, Mukamel DB, Dick AW. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg. 2011;146(7):794-801.
33. Collins AS. Chapter 41: Preventing health care-associated infections. In: Hughes RG, ed. Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Rockville, MD: Agency for Healthcare Research and Quality; 2008. p. 1-29. AHRQ Publication No. 08e0043.
34. Shah BR, Patel MR, Peterson ED, Douglas PS. Defining optimal research study design of cardiovascular imaging using computer tomography angiography as a model. Am J Cardiol. 2008;102(7):943-948.
35. Cardo D, Dennehy PH, Halverson P, et al. Moving toward elimination of healthcare-associated infections: a call to action. Infect Control Hosp Epidemiol. 2010;31(11):1104.
36. Chernecky C. In-vitro connector research [editorial]. Clin Infect Dis. 2010;51(12):1463.
37. Chernecky C, Casella L, Jarvis E, Macklin D, Rosenkoetter M. Nurses' knowledge of intravenous connectors. J Res Nurs. 2010;15:405-416.
38. Chernecky C, Jarvis WR, Waller JL, Macklin D. In-vitro study documenting the lack of antibacterial activity of three silver-impregnated/coated mechanical valve needleless connectors after blood exposure. Poster presented at the 2011 Council for the Advancement of Nursing Science Special Topics Conference, Washington, DC, October 12, 2011.
39. Chernecky C, Waller J. In vitro comparisons of two antimicrobial intravenous connectors. Clin Nurs Res. 2011;20(1):101-109.
40. Chernecky C, Waller J. Comparative evaluation of five needleless intravenous connectors. J Adv Nurs. 2011;67(7):1601-1613.
41. Chernecky C, Waller J, Macklin D, Caillouet B. Comparative effectiveness of intravenous catheter connectors. Poster presented at the 2011 National Teaching Institute and Critical Care Exposition, Chicago, IL, May 3, 2011.
42. Chernecky C, Waller J, Jarvis W. In-vitro study assessing the antibacterial activity of three silver-impregnated/coated mechanical valve needleless connectors after blood exposure. Am J Infect Control. 2013;41:278-280.
43. Velentgas P, Dreyer NA, Wu AW. Chapter 6: Outcome definition and measurement. In: Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, eds. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide. Rockville, MD: Agency for Healthcare Research and Quality; 2013. p. 71-92. AHRQ Publication No. 12(13)-EHC099.
44. Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and Congress. http://www.hhs.gov/recovery/programs/cer/ cerannualrpt. pdf. 2009. Accessed May 21, 2013.
45. Arbogast PG, VanderWeele TJ. Chapter 10: Considerations for statistical analysis. In: Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, eds. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide. Rockville, MD: Agency for Healthcare Research and Quality; 2013. p. 135-144. AHRQ Publication No. 12(13)-EHC099.
46. Barnard A, Sandelowski M. Technology and humane nursing care: (Ir)reconcilable or invented difference? J Adv Nurs. 2001;34(3):367-375.
47. Hurlock-Chorostecki C. Holistic care in the critical care setting: application of a concept through Watson's and Orem's theories of nursing. Can Assoc Crit Care Nurs. 1999;10(4):20-25.
48. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidineimpregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231-1241.
49. Mermel LA, Marschall J. Reply to Edgar. Infect Control Hosp Epidemiol. 2009;30:403-404.
50. Ahern RL, Corless IB, Davis SM, Kwong JJ. Infusing Swanson's theory of caring into an advanced practice nursing model for infectious diseases anal dysplasia clinic. J Assoc Nurses AIDS Care. 2011;22(6):478-488.
51. Christenbery TL. Building a schematic model: a blueprint for DNP students. Nurse Educ. 2011;36(6):250-255.